From the clip:
“We are excited to test sozinibercept in large P3 programmes […] with the goal of […] showing that we can improve visual acuity hopefully by up to 5 letters or more.“
To my memory, this is the first time somebody sharing responsibility for running the trials dares to explicitly mention a „5 letters or more“ improvement as what OPT internally is really hoping for. If this hope materializes then Eichenbaum is absolutely right saying that sozinibercept would disrupt the wAMD market.
I just cannot believe existing players continuing to stay quiet with this disruptive opportunity being up for sale / partnership just 15 months ahead of P3 results. Therefore, I’d indeed expect a partnership occurring over the next 3 months being more probable than a classic CR.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024, page-42
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
76.5¢ |
Change
0.040(5.52%) |
Mkt cap ! $920.2M |
Open | High | Low | Value | Volume |
72.5¢ | 76.5¢ | 72.5¢ | $4.542M | 6.069M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 83334 | 76.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.5¢ | 149449 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 74150 | 0.755 |
11 | 110821 | 0.750 |
7 | 112447 | 0.745 |
9 | 23599 | 0.740 |
4 | 9153 | 0.735 |
Price($) | Vol. | No. |
---|---|---|
0.765 | 163769 | 30 |
0.770 | 73436 | 15 |
0.775 | 138757 | 9 |
0.780 | 403081 | 9 |
0.785 | 35509 | 4 |
Last trade - 15.23pm 25/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online